1-2 of 2
Keywords: Pathological complete response
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Effect of Positron Emission Tomography-Computed Tomography Parameters on Pathological Response in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Treatment

Available to Purchase
Subject Area:
Oncology
Serhat Sekmek, Ozkan Bayrakcı, Mehmet Akif Karacan, Irfan Karahan, Sema Nur Ozsan Celebi, Didem Sener Dede, Efnan Algin, Berna Okudan, Oznur Bal
Journal: Oncology Research and Treatment
Oncol Res Treat (2025)
https://doi.org/10.1159/000545820
Published Online: 10 April 2025
.... 2025 Introduction: We aimed to evaluate the relationship between positron emission tomography (PET)/computed tomography (CT) parameters with pathological complete response (pCR) in patients with HER-2-positive breast cancer who received neoadjuvant treatment (NACT). Methods...
View articletitled, The Effect of Positron Emission Tomography-Computed Tomography Parameters on Pathological Response in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Treatment
Open the PDF for The Effect of Positron Emission Tomography-Computed Tomography Parameters on Pathological Response in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Treatment in another window
Journal Articles

Expression of BCRP/ABCG2 Protein in Invasive Breast Cancer and Response to Neoadjuvant Chemotherapy

Available to Purchase
Subject Area:
Oncology
Yan Shou Zhang, Chao Yang, Lei Han, Lei Liu, Yun Jiang Liu
Journal: Oncology Research and Treatment
Oncol Res Treat (2022) 45 (3): 94–101.
https://doi.org/10.1159/000520871
Published Online: 12 November 2021
... pathological complete response (pCR) rate of 38%, higher than the 19% in tumors with high BCRP/ABCG2 expression ( p = 0.002). In multivariable analysis, BCRP/ABCG2 and hormone receptor (HR) expression were identified as independent risk factors of pCR ( p = 0.003 and p = 0.013, respectively). Conclusions: BCRP...
View articletitled, Expression of BCRP/ABCG2 Protein in Invasive Breast Cancer and Response to Neoadjuvant Chemotherapy
Open the PDF for Expression of BCRP/ABCG2 Protein in Invasive Breast Cancer and Response to Neoadjuvant Chemotherapy in another window